Search Results for:

Seed funding for ACTA was provided by the Victorian Department of Health in 2013, with a second allocation of funding from the Victorian Department of Health and Human Services in…

ACTA welcomes back Adaptive Trial design expert Scott Berry to provide an overview of FDA guidance released for Adaptive Designs for Clinical Trials of Drugs and Biologics. You can download…

A video from the Consumer Involvement and Engagement Toolkit…

A video from the Consumer Involvement and Engagement Toolkit…

ACTA’s Board of Directors is responsible for the corporate governance and financial management of the organisation. Australian Clinical Trials Alliance Limited (ACN 168 693 972) is a not-for-profit public company limited by…

OUR VISION Better health through best evidence OUR MISSION AND OBJECTIVES ACTA was established to advance health by: promoting the role of investigator‐initiated clinical trials and clinical quality registries to…

It’s often assumed that clinical decision-making is supported by high quality evidence derived from clinical trials. Unfortunately, this is not the case. Many clinical decisions in medicine are based on…

Clinical Trials Networks (CTNs) are collaborative groups of practising clinician-researchers. While some trials are conducted in collaboration with industry, the majority focus on investigator-initiated trials providing unbiased, high-quality scientific evidence…

ACTA develops strong partnerships and models of engagement with stakeholders that share ACTA’s mission. These groups include: Commonwealth and state governments Hospitals and health services Patient and consumer groups Research funders Universities…

2020–2024 MRFF Enhancing Clinical Trials Network Capabilities Grant This Activity Plan outlines key activities to be undertaken by ACTA during 2020-2024 Grant outcomes: To consolidate and strengthen sector capability and…

Australasian Gastro-Intestinal Trials Group 22nd Annual Scientific Meeting Online meeting Convenor: Professor Stephen Ackland The AGITG Annual Scientific Meeting serves not only as a forum for the presentation of state-of-the art overviews…

CT:IQ is conducting a project assessing the barriers and enablers to clinical trials recruitment at the site level. This survey will assist CT:IQ to produce recommendations for optimising recruitment to…

Melanoma and Skin Cancer Trials (MASC Trials) have had a busy few months with many activities including a name change, the establishment of a Merkel Cell Carcinoma (MCC) Interest Group,…

Mission: SIGNet’s mission is to support and advocate for CTN managers, thereby optimising operational management of CTNs and supporting the delivery of high-quality clinical research. Purpose: SIGNet provides a forum…

At the AGM, we welcomed three new Directors and celebrated a breadth of expertise that represents productive diversity We are delighted to welcome Associate Professor Rachael Morton and Ms Leonie…

Following a sector consultation of Clinical Trial Networks (CTNs), ACTA has established the three elements crucial to network success are sustainability, engagement and infrastructure. This report highlights opportunities for the…

The ACTA Trial of the Year Awards were established in 2016 and has been traditionally celebrated in International Clinical Trials day in May, as part of a National Tribute and…

ANZUP’s Annual Scientific Meeting (ASM) (#ANZUP21) provides a platform to discuss and present the latest updates in GU cancer treatment, research and supportive care, and to learn more about existing…

Clinical Trial Manager – IVCare Adaptive Platform Trial Employment Type: Full-time (100%), fixed-term position for up to 2 years Position Classification: Health Manager Level 3 Remuneration: $113,377 – $127,112 +…

One of the biggest dates on the ACTA calendar is International Clinical Trials Day on 20 May, which we acknowledge and celebrate with our National Tribute and Awards Ceremony. Details…

Want to be part of the ACTA team? An opportunity has arisen for a talented individual to join our Project Team as a Project Officer. The successful candidates will help us…

Together, we’ve achieved a great deal over the last year, including a new Consumer Involvement award at the Clinical Trials 2019: National Tribute and Award Ceremony (aka Trial of the…

Each month we profile an ACTA Member, to get an update about their achievements and to find out what ACTA means to them. PREDICT (Paediatric Research in Emergency Departments International…

Super webinar On Tuesday 11 February 2020 ACTA will hold its biggest webinar to date—the Super Webinar to disseminate and open communication around a document ACTA has created to guide…

The holiday season is officially upon us, so from the ACTA Board of Directors and staff, we’d like to wish you a fabulous festive season. ACTA Central will be closed…

The webinar will teach participants best-practice for clinical trials and will be relevant to anyone in the healthcare sector. ‘In order to be useful, clinical research should be true, but…

The webinar will teach participants best-practice for clinical trials and will be relevant to anyone in the healthcare sector. ‘In order to be useful, clinical research should be true, but…